Metabolic bone disease: from basic science to clinical frontier

References

[1] Zeng LF,Liang GH.Does routine anti-osteoporosis medication lower the risk of fractures in male subjects? An updated systematic review with meta-analysis of clinical trials.Front Pharmacol2019;10:882 PMCID:PMC6695469

[2] Zeng LF.Editorial: The potential effects and mechanisms of Chinese traditional medicine on bone homeostasis and remodeling, volume II.Front Endocrinol2023;14:1158042 PMCID:PMC10111254

[3] Zhao Z,Chen A,Yang K.Application of metabolomics in osteoporosis research.Front Endocrinol2022;13:993253 PMCID:PMC9702081

[4] Xia TS. Metabolomics study of antiglucocorticoid-induced osteoporosis in Morindae Officinalis Radix and Prepared rhizome of Adhesive Rehmannia. PLA Navy Medical University; 2019 (in Chinese). Available from: https://kns.cnki.net/kcms2/article/abstract?v=lVku9qtM8H-4QGPWbql1lo2IwoqzvLXPJtPE7E2FE2bbYRKWGKNe7HeTQSz8ML-hJFbtg4UPzsETejEjM5K7u7u_5BvajyHEE1SdoTLUlBwaffjZ3D-7ZSc1ebWSxQ2srx397KDx_WnrHt0HjuRkbw==&uniplatform=NZKPT&language=CHS [Last accessed on 30 Nov 2023]

[5] Pan S,Han Z,Lu X.¹H NMR-based metabonomic study on the effects of Epimedium on glucocorticoid-induced osteoporosis.J Chromatogr B Analyt Technol Biomed Life Sci2016;1038:118-26

[6] Wang FJ,Luo FM,Liu S.Study on anti-osteoporosis effect of Eucommiae Cortex based on GC-MS metabonomics.Zhongguo Zhong Yao Za Zhi2020;45:5555-60

[7] Huang Y,Zhao L,Xiong Z.Kidney tissue targeted metabolic profiling of glucocorticoid-induced osteoporosis and the proposed therapeutic effects of Rhizoma Drynariae studied using UHPLC/MS/MS.Biomed Chromatogr2014;28:878-84.

[8] Jiang YC,Zhou L.UPLC-MS metabolomics method provides valuable insights into the effect and underlying mechanisms of Rhizoma Drynariae protecting osteoporosis.J Chromatogr B Analyt Technol Biomed Life Sci2020;1152:122262

[9] Li C. Study on anti-osteoporosis mechanism of Shen-Ling Jian-Gu Capsule based on metabonomics. Hebei Medical University; 2017 (in Chinese). Available from: https://kns.cnki.net/kcms2/article/abstract?v=lVku9qtM8H8IvNiLGFNbKa1o9rzO-LljuwtRmSvLMVM5sYn55p9oLlvEqLwzbtV9nnN68xb3YKh2lcbWw-47JiTw0IQKpYlx2mNU6Mb7YgFop0QZNSMrL3nxXMBSukjT26QR4YbIW-mzURgYx7Wl1Q==&uniplatform=NZKPT&language=CHS [Last accessed on 30 Nov 2023]

[10] Luo D,Chen K,Guo J.Untargeted metabolomics reveals the protective effect of Fufang Zhenshu Tiaozhi (FTZ) on aging-induced osteoporosis in mice.Front Pharmacol2018;9:1483 PMCID:PMC6331458

[11] Wu F. Study on metabonomics of Shu-Gan Bu-Shen Formula in treating osteoporosis. Zhejiang Chinese Medicine University; 2016 (in Chinese). Available from: https://kns.cnki.net/kcms2/article/abstract?v=lVku9qtM8H9eqE28el0MrFPUFs01dn2MbWz3jOswEKaYUgGFhMZNAyXwKqyEjzUbeKlDc-mQs0Nw7aukORBqCYDJ38xQzTSI8Psg1RQJRtx-VrFaca1dIiT90Mm6uYnYXYfU6W06ckV5xLrbdAhOOQ==&uniplatform=NZKPT&language=CHS [Last accessed on 30 Nov 2023]

[12] Liu WJ,Huang MY,Sun P. Serum metabolomics study of Jian-Gu Granule against osteoporosis in ovariectomized rats. Chin J Osteoporosis 2021;27:1820-6 (in Chinese). Available from: https://kns.cnki.net/kcms2/article/abstract?v=lVku9qtM8H_PxItAvVTgZ0FQq7Ou0IRw43hh9WY78ncwGTSe-Hd8M6lclJPtvpkGoko0ayjPKpPevz7leKRiFItcdFbvVSLirlxVZV5pec8QJU33QANS2Fhz5n8RHuewPKqaA0TAGtv89YTufR2qpA==&uniplatform=NZKPT&language=CHS [Last accessed on 30 Nov 2023]

[13] Yuan XM,Jia HW,Zhao J.Metabomic study of GC-MS based Gu-Shu Dan on prevention of glucocorticoid-induced osteoporosis.Journal of Shenyang Pharmaceutical University2021;38:1033-9

[14] Xu XX. Pharmacodynamics and metabolomics of cistanche deserticola and its active components against osteoporosis. Ningxia Medical University; 2018 (in Chinese). Available from: https://kns.cnki.net/kcms2/article/abstract?v=lVku9qtM8H_IsPy1piezgCxzLhwg5x5FpLvjn0oCO8nbHRJ2OaJxDw8c02Yf_Q7FuTIZZmjZS3ElLz4k0JK_4MY7FsHNxObzR9ZOY-c7CthKl7n8GT54EMVx59-XAua2seROrNr9I6FkpR34wTTVGg==&uniplatform=NZKPT&language=CHS [Last accessed on 30 Nov 2023]

[15] Zhang AH,Sun H.High-throughput metabolomics evaluate the efficacy of total lignans from acanthophanax senticosus stem against ovariectomized osteoporosis rat.Front Pharmacol2019;10:553 PMCID:PMC6548904

[16] Ma YS,Li Y,Wang JM.Unveiling the pharmacological mechanisms of eleutheroside E against postmenopausal osteoporosis through UPLC-Q/TOF-MS-based metabolomics.Front Pharmacol2020;11:1316. PMCID:PMC7479840

[17] Si Z,Shen Z.High-throughput metabolomics discovers metabolic biomarkers and pathways to evaluating the efficacy and exploring potential mechanisms of osthole against osteoporosis based on UPLC/Q-TOF-MS coupled with multivariate data analysis.Front Pharmacol2020;11:741 PMCID:PMC7326133